BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 16876913)

  • 1. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
    Swerdlow RH
    Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
    Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
    Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P).
    Koopman K; Le Bastard N; Martin JJ; Nagels G; De Deyn PP; Engelborghs S
    Neurochem Int; 2009 Sep; 55(4):214-8. PubMed ID: 19524111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Hardy J; Selkoe DJ
    Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-beta, tau, and dementia.
    Takashima A
    J Alzheimers Dis; 2009; 17(4):729-36. PubMed ID: 19542626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease: report of two autopsy cases with a clinical diagnosis of corticobasal degeneration.
    Okazaki K; Fu YJ; Nishihira Y; Endo M; Fukushima T; Ikeuchi T; Okamoto K; Onodera O; Nishizawa M; Takahashi H
    Neuropathology; 2010 Apr; 30(2):140-8. PubMed ID: 19780981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomedicine. Tauists and beta-aptists united--well almost!
    Lee VM
    Science; 2001 Aug; 293(5534):1446-7. PubMed ID: 11520974
    [No Abstract]   [Full Text] [Related]  

  • 9. Alois Alzheimer and Alzheimer's disease: a centennial perspective.
    Small DH; Cappai R
    J Neurochem; 2006 Nov; 99(3):708-10. PubMed ID: 17076655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazin red as a neuropathological tool for the rapid diagnosis of Alzheimer's disease in tissue imprints.
    Luna-Muñoz J; Peralta-Ramirez J; Chávez-Macías L; Harrington CR; Wischik CM; Mena R
    Acta Neuropathol; 2008 Nov; 116(5):507-15. PubMed ID: 18810470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.
    Masters CL; Cappai R; Barnham KJ; Villemagne VL
    J Neurochem; 2006 Jun; 97(6):1700-25. PubMed ID: 16805778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes.
    MacDonald AB
    Med Hypotheses; 2007; 68(4):822-5. PubMed ID: 17055667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
    Flood DG; Lin YG; Lang DM; Trusko SP; Hirsch JD; Savage MJ; Scott RW; Howland DS
    Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early diagnostic accuracy and pathophysiologic relevance of an autopsy-confirmed Alzheimer's disease peripheral biomarker.
    Khan TK; Alkon DL
    Neurobiol Aging; 2010 Jun; 31(6):889-900. PubMed ID: 18760507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease.
    Prohovnik I; Perl DP; Davis KL; Libow L; Lesser G; Haroutunian V
    Neurology; 2006 Jan; 66(1):49-55. PubMed ID: 16401845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuropathologic investigation in autopsies with special emphasis on findings in Alzheimer's disease].
    Leel-Ossy L; Kindler M; Szucs I; Schwarcz T
    Ideggyogy Sz; 2006 May; 59(5-6):164-77. PubMed ID: 16786711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis.
    Suzuki T; Araki Y; Yamamoto T; Nakaya T
    J Biochem; 2006 Jun; 139(6):949-55. PubMed ID: 16788045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR1 is an early and specific marker of Alzheimer's disease.
    Halks-Miller M; Schroeder ML; Haroutunian V; Moenning U; Rossi M; Achim C; Purohit D; Mahmoudi M; Horuk R
    Ann Neurol; 2003 Nov; 54(5):638-46. PubMed ID: 14595653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.